Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer Research DOI Open Access
Nilesh Kumar Sharma, Sachin C. Sarode

Cancers, Год журнала: 2024, Номер 16(21), С. 3646 - 3646

Опубликована: Окт. 29, 2024

Artificial intelligence (AI), encompassing several tools and platforms such as artificial “general” (AGI) generative (GenAI), has facilitated cancer research, enhancing productivity in terms of research publications translational value for patients. AGI tools, ChatGPT, assist preclinical clinical scientists identifying tumor heterogeneity, predicting therapy outcomes, streamlining publications. However, this perspective review also explores the potential AI’s influence on with regard to its impact disruptive sciences discoveries by scientists. The increasing reliance AI may compromise biological intelligence, disrupting abstraction, creativity, critical thinking. This could contribute declining trend sciences, hindering landmark innovations. narrates role different forms potentiation productive disruption due influence.

Язык: Английский

Future prospective of AI in drug discovery DOI
Mithun Bhowmick, Sourajyoti Goswami, Pratibha Bhowmick

и другие.

Advances in pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice DOI Creative Commons
Monika Berezowska,

Isaac S. Hayden,

Andrew M. Brandon

и другие.

British Journal of Clinical Pharmacology, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

Current methods of dose determination have contributed to suboptimal and inequitable health outcomes in underrepresented patient populations. The persistent demand individualise treatment, alongside increasing technological feasibility, is leading a growing adoption model‐informed precision dosing (MIPD) at point care. Population pharmacokinetic (popPK) modelling technique that supports treatment personalisation by characterising drug exposure diverse groups. This publication addresses this important shift clinical approach, collating summarising recommendations from literature. It seeks provide standardised guidelines on best practices for the development popPK models their use MIPD software tools, ensuring safeguarding optimisation outcomes. Moreover, it consolidates guidance key regulatory advisory bodies deployment, as well technical requirements electronic record integration. also considers future application impact machine learning algorithms MIPD. Ultimately, aims facilitate incorporation high‐quality precision‐dosing solutions into standard workflows, thereby enhancing effectiveness individualised selection

Язык: Английский

Процитировано

2

Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer Research DOI Open Access
Nilesh Kumar Sharma, Sachin C. Sarode

Cancers, Год журнала: 2024, Номер 16(21), С. 3646 - 3646

Опубликована: Окт. 29, 2024

Artificial intelligence (AI), encompassing several tools and platforms such as artificial “general” (AGI) generative (GenAI), has facilitated cancer research, enhancing productivity in terms of research publications translational value for patients. AGI tools, ChatGPT, assist preclinical clinical scientists identifying tumor heterogeneity, predicting therapy outcomes, streamlining publications. However, this perspective review also explores the potential AI’s influence on with regard to its impact disruptive sciences discoveries by scientists. The increasing reliance AI may compromise biological intelligence, disrupting abstraction, creativity, critical thinking. This could contribute declining trend sciences, hindering landmark innovations. narrates role different forms potentiation productive disruption due influence.

Язык: Английский

Процитировано

0